Skip to main content
. 2017 Dec 20;9(4):4707–4721. doi: 10.18632/oncotarget.23523

Table 1. Correlation between SMOC1 methylation and the clinicopathological features of non-invasive colorectal tumors.

SMOC1 methylation
<36% (n = 376) ≥36% (n = 97) P
Age (y, mean ± SD) 64.0 ± 11.1 68.6 ± 11.2 <0.001
Gender
 Female 112 31 NS
 Male 264 66
Location
 Proximal 186 50 NS
 Distal 190 47
Size (mm, mean ± SD) 10.6 ± 6.8 18.1 ± 13.0 <0.001
Morphology
 Depressed 2 1 NS
 Flat 192 63
 Flat plus protruding 14 9
 Protruding 136 58
Histology
 HP 51 1 <0.001
 SSA/P 104 3
 SSA/P + CD 23 3
 SSA/P + cancer 11 3
 TSA 31 16
 TSA + cancer 0 8
 Low-grade adenoma 64 10
 High-grade adenoma 53 32
 Cancer 39 21
BRAF
 Mut 151 19 <0.001
 WT 225 78
KRAS
 Mut 74 50 <0.001
 WT 302 47
TP53
 Mut 26 14 0.018
 WT 350 83
CIMP status
 Negative 248 57 0.010
 Low 50 25
 High 78 15
MLH1 methylation
 Methylated 18 2 NS
 Unmethylated 358 95

NS, not significant; CD, cytological dysplasia; Mut, mutated; WT, wild type.